Strong YoY Growth Can't Hide a Faltering Quarter

Crompton Greaves delivered a headline result that ticks all the boxes: revenue +18.2% YoY to ₹2,263 Cr, PAT +64.9% to ₹124.4 Cr, EBITDA up 24.1% with 40 basis points of margin expansion to 9%. The pricing narrative holds — 15–16% cumulative price hikes across the portfolio, 80% cost pass-through in Q2. On the surface, a quarter where pricing power tested and held, and where Crompton 2.0 (the company's multi-vector growth strategy) is firing.

But look one row down on the P&L. Q2 PAT declined 12.8% quarter-on-quarter — from ₹142 Cr (implied Q1) to ₹124.4 Cr in Q2. This is not a rounding error. It contradicts the framing on the call that "Q2 started well" and that the company is "entering the second half with tremendous momentum." Management did not address this reversal in the opening remarks or the Q&A. That silence is deafening.

This quarter is not what it looks like at first glance.

PAT growth of 65% YoY is real, but PBT growth was only 36.2% (excluding the ₹20 Cr exceptional gain in Q2 FY26). This tells you that operating leverage — the core of the Crompton 2.0 narrative — was not the primary driver. Instead, a step-function price increase in Q1 (ahead of cost inflation) pulled forward profit, and Q2 is the normalization. Management's own guidance ("FY27 entry with momentum") suggests this is the trajectory: a burst in Q1, then settling into a higher baseline in Q2 and beyond.

The QoQ PAT decline of 12.8% is not a blip. It suggests that H2 (and likely Q3 onwards) will face either continued demand normalization or fresh cost headwinds. Without an explicit statement from management addressing this, the market is right to price in caution.

Management frames the medium term around three pillars: (1) core fan/appliance leadership with pricing power, (2) new adjacencies (Wires, Solar Rooftop B2C/C&I, Butterfly restructuring), and (3) EBITDA margin ambition of 11–12% by FY29 via a 2.5x acceleration in growth from the prior 6% baseline to mid-teens. This is not conservative. It is a bet that Crompton can 2.5x growth, absorb new-business mix shifts, and still expand margins by 200+ basis points from current 9% to 11–12%.

The near-term execution is visible: solar rooftop TAM of ₹26,000 Cr, wires rollout to 7 states, Butterfly repositioning underway. All real. But new businesses are ~10% of Q2 revenue and their margin profiles are opaque — the data doesn't break out whether Wires and Solar Rooftop B2C/C&I are higher or lower margin than the core. If they are lower margin, then 14–15% long-term revenue contribution from new businesses will be a headwind to consolidated margin, not a tailwind. Management needs to prove otherwise.

The market has rendered its verdict in real time. Crompton is trading at ₹195.18, down 61.94% from its all-time high and below all key moving averages (SMA20 ₹209.54, SMA50 ₹225.14, SMA200 ₹250.51). More tellingly, FII ownership has declined from 30.34% in Q4 FY25 to 19.89% in Q1 FY27 — a 1,045 basis-point exodus over five quarters. DII has stepped in but not filled the gap. This is not passive rotation; this is deliberate institutional selling.

The drawdown is severe, and the stock is off the 52-week low by only 1.63%. Volume is increasing, which could signal either capitulation (final sellers) or early accumulation (patient capital awaiting clarity). The RSI of 30.4 is neutral territory, not oversold — suggesting there is no mechanical bounce imminent. The market is waiting for evidence that Crompton 2.0 execution is real and that the QoQ profit decline is not the start of a downward spiral.

The single number to track from here is Q3 FY27 QoQ PAT. If it is stable or grows (≥₹120 Cr), the QoQ decline was a one-time normalization and the momentum narrative holds. If it contracts further (< ₹115 Cr), the bear case (demand softening or new cost headwinds) is in play. That one figure will determine whether Crompton 2.0 is real or aspirational.

Beyond that, monitor: (1) margin bridge — how much of the 11–12% FY29 target comes from revenue scale vs. cost initiatives vs. mix shift; (2) new business contribution — granular data on Wires and Solar Rooftop EBIT, not just revenue; (3) government order flow — Kusum 2.0 and AP solar rooftop follow-on orders; (4) capex capital allocation — greenfield plant timeline and expected ROIC. These will validate whether Crompton can execute or whether the strategy is a wish rather than a plan.